Markets:

Overview

News

Currencies

International

Treasuries

Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

17.30 -0.10 (-0.57%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Summit Therapeutics Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

18 19 Next >

3 Magnificent Stocks Under $100 to Buy in November ↗

November 03, 2024

The price could be right for these stocks.

Via The Motley Fool

2 Dividend Stocks to Buy for a Lifetime of Passive Income ↗

November 02, 2024

These are the kinds of stocks that can allow investors to sleep easy at night.

Via The Motley Fool

3 Stocks That Have Generated 1,000% Returns in Just 2 Years ↗

October 31, 2024

Should you add these fast-growing stocks to your portfolio?

Via The Motley Fool

Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024

October 30, 2024

From Summit Therapeutics Inc.

Via Business Wire

Preview: Summit Therapeutics's Earnings ↗

October 29, 2024

Via Benzinga

(SMMT) - Analyzing Summit Therapeutics's Short Interest ↗

October 10, 2024

Via Benzinga

From Nuvalent to Nuvectis Pharma: New Report Highlights NXP900's Synergy in NSCLC and Anticipated NXP800 Data Update

October 28, 2024

The report covers Nuvectis (NASDAQ: NVCT) alongside notable similar precision oncology players such as Nuvalent ($6.6B) and Summit Therapeutics ($15B).

Via News Direct

Is Summit Therapeutics a Millionaire Maker? ↗

October 27, 2024

The potential upside of this stock is undeniably meaty.

Via The Motley Fool

Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising? ↗

October 24, 2024

This drugmaker's lead candidate could become a top-selling cancer therapy.

Via The Motley Fool

Billionaire Bob Duggan Snags $33M Miami Penthouse Amid Summit Therapeutics 689% Stock Rally ↗

October 24, 2024

Duggan, an 80-year-old originally from California, was particularly impressed by the breathtaking views from the 57th floor.

Via Benzinga

Summit Therapeutics to Host Third Quarter 2024 Financial Results & Operational Progress Call on October 30, 2024

October 23, 2024

From Summit Therapeutics Inc.

Via Business Wire

Billionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You? ↗

October 22, 2024

Millennium Management just initiated a position in a small biotech company developing a new cancer drug.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 16, 2024

Via Benzinga

Up 700% This Year, Is It Too Late to Invest in This Stock? ↗

October 15, 2024

The shares have experienced a pullback in the past couple of weeks.

Via The Motley Fool

Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics ↗

October 13, 2024

It's hard to go wrong with either company, but one is more appealing.

Via The Motley Fool

3 Things You Need to Know If You Buy Summit Therapeutics Stock Today ↗

October 12, 2024

It's easier to invest confidently when you know both the pros and the cons in full.

Via The Motley Fool

2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts ↗

October 07, 2024

The investment bank analysts who follow these stocks think they can soar even further, with some caveats.

Via The Motley Fool

Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio? ↗

October 06, 2024

Eleven large-cap stocks were worst performers last week. Decline in Stars performance and sales, regulations and supply issues caused the drop.

Via Benzinga

Is Summit Therapeutics a Millionaire Maker? ↗

October 05, 2024

This company's promising cancer drug could challenge Merck's $25 billion crown jewel.

Via The Motley Fool

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 04, 2024

From Summit Therapeutics Inc.

Via Business Wire

Could Summit Therapeutics Become the Next Merck? ↗

October 04, 2024

Recent developments are forcing comparisons between these two drugmakers.

Via The Motley Fool

Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket ↗

October 04, 2024

Via Benzinga

Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC

October 03, 2024

From Summit Therapeutics Inc.

Via Business Wire

Where Will Summit Therapeutics Be in 3 Years? ↗

October 03, 2024

There's a lot riding on how its collaborator's studies end up performing.

Via The Motley Fool

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank? ↗

October 02, 2024

A look at the 20 most searched tickers on Benzinga Pro, which includes many familiar names and some penny stocks that may be less familiar.

Via Benzinga

Has Summit Therapeutics Stock Already Peaked? ↗

October 02, 2024

Summit Therapeutics stock is up a remarkable 700% this year.

Via The Motley Fool

Is Summit Therapeutics Stock a Buy? ↗

September 30, 2024

Its alliance with a successful foreign biotech could be decisive for the stock.

Via The Motley Fool

Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio? ↗

September 29, 2024

10 worst performing large-cap stocks last week: SMMT, MMYT, MEDP, REGN, GPN, AFRM, SMCI, FTI, FCNCA, NOW. Are they in your portfolio?

Via Benzinga

2 High-Potential Growth Stocks You Shouldn't Overlook ↗

September 29, 2024

These two growth stocks have plenty of room to run.

Via The Motley Fool

Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics ↗

September 28, 2024

One of them is performing much better than the other this year.

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.